consulting servicesMedtech and life sciences consultingOur medtech and life sciences consultancy supports your corporate and commercial needs. We empower you to define your strategies and influence your customers with our distinctive deep country and regional analysis, healthcare expertise and data-driven intelligence. We also provide health-policy analysis, thought leadership and macroeconomic country insights to deliver an essential advisory service. Inquire now
Why Clearstate consulting?Our specialist consultants are fully immersed in the medtech and life sciences sectors. We enable confident decision-making with actionable insights that advance your strategy.
Medtech specialisation and deep domain expertise Our team of consultants and analysts combine local-market knowledge and industry acumen to deliver an end-to-end consulting service, across world markets.
Existing medtech market data to leverage onThrough our Gateway platform, you can gain access to our proprietary market data—covering major medical-device sectors. Identify market opportunities and formulate growth strategies with these essential insights.
Rich history of medtech collaborationTop healthcare and medical-device companies worldwide rely on our consultancy services to support a range of functions—from corporate strategy and strategic planning to market access and commercial initiatives.
Global reach, micro depthOur robust network of opinion leaders and medtech and life sciences professionals provides insights that inform decision-making.
Growth and innovation strategies Identify greenfield opportunities and innovative solutionsAnalyse emerging-market demand
Strategic marketing Assess opportunities to enter new market segments and geographiesGet risk-impact analysis
Access and pricing strategies Explore payer and health systems analysis, covering reimbursement changes, policy and regulatory reformsEvaluate price-demand, price sensitivity and affordability to set optimal pricing strategies
Holistic planning and implementation strategies Define business, commercial and operational modelsPrioritise business initiatives and track outcomesEstablish performance metrics and monitor results
Clearstate Insights Driving better diagnostic discovery for patients with Rebecca Middleton, vice chair of the participant panel at Genomics England The impact of genomics on global healthcare is one to watch. Genomic testing is improving the diagnosis and treatment of diseases including cancer, genetic and infectious diseases; driving the delivery of more personalised care. In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Clearstate Insights Enabling faster diagnosis of rare diseases: Interview with HBA Support’s Rebecca Middleton In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Clearstate Insights How government policies will drive China’s robotic surgery market Orthopaedic & Spine Surgery | Robotic surgery | Surgical device and IVD | Uncategorised | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
Clearstate Insights The future of thalassemia care In-vitro diagnostics | Next Generation Sequencing (NGS) | IVD Gateway | Next Generation Sequencing (NGS)